Ameloblastoma medical therapy

Revision as of 18:41, 23 December 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Ameloblastoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ameloblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ameloblastoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ameloblastoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ameloblastoma medical therapy

CDC on Ameloblastoma medical therapy

Ameloblastoma medical therapy in the news

Blogs on Ameloblastoma medical therapy

Directions to Hospitals Treating Ameloblastoma

Risk calculators and risk factors for Ameloblastoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Medical Therapy

Ameloblastomas are relatively resistant to chemotherapy or radiation therapy, thus surgery is the most common treatment of this tumor.

References

Template:WH Template:WS